Clinical trial
Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant…
NCT00063648 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00063648 |
|---|---|
| Title | Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Liver Disease, Lymphoproliferative Disorders |
| Intervention type | Biological |
| Interventions | EBV-specific autologous CTL |
| Enrollment | 50 |
| Start date | May 1, 2002 |
| Completion | Dec 1, 2007 |
| First posted | Jul 3, 2003 |
| Last update posted | Jan 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: